Magnesium in PDB 4j96: Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.

Enzymatic activity of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.

Protein crystallography data

Magnesium Binding Sites:

Magnesium binding site 1 out of 1 in 4j96

Magnesium Binding Sites List in 4j96

Magnesium binding site 1 out of 1 in the Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer. within 5.0Å range: probe atom residue distance (Å) B Occ B:Mg805 b:60.0 occ:1.00 O1A B:ACP803 2.1 0.1 1.0 H8 B:ACP803 3.1 35.7 1.0 H3B1 B:ACP803 3.2 0.3 1.0 NZ B:LYS517 3.2 58.1 1.0 PA B:ACP803 3.2 0.9 1.0 O5' B:ACP803 3.2 65.4 1.0 H2' B:ACP803 3.6 57.0 1.0 OD2 B:ASP644 3.7 49.4 1.0 O1G B:ACP803 3.7 0.5 1.0 CG B:ASP644 4.0 48.7 1.0 C8 B:ACP803 4.1 29.8 1.0 C3B B:ACP803 4.1 96.9 1.0 O B:HOH988 4.1 37.3 1.0 CE B:LYS517 4.2 52.0 1.0 O2A B:ACP803 4.3 0.1 1.0 O3A B:ACP803 4.3 0.5 1.0 CB B:ASP644 4.4 36.7 1.0 PG B:ACP803 4.5 0.8 1.0 CG2 B:VAL495 4.5 28.4 1.0 C2' B:ACP803 4.5 47.5 1.0 H3' B:ACP803 4.6 63.1 1.0 C5' B:ACP803 4.6 57.7 1.0 OD1 B:ASP644 4.7 52.9 1.0 H3B2 B:ACP803 4.7 0.3 1.0 N7 B:ACP803 4.8 32.7 1.0 PB B:ACP803 4.9 0.3 1.0 OD1 B:ASN631 5.0 21.2 1.0

Reference: